Multichannel data is scattered and messy.
How can efficient, secure, and compliant management help enterprises better understand users and build effective interactions to accelerate business growth?
Take a look at how AWS worked with MeDomino, a partner focused on digital intelligence innovation in pharma, to use cloud services to help pharma companies build the digital asset management solution ADAL.
Scattered Multichannel Data
How Can It Be Managed Efficiently, Securely, and Compliantly?
In the rapidly changing pharmaceutical industry, marketing strategy is undergoing a profound transformation. Traditional resource-oriented marketing is gradually giving way to more professional, compliant, and personalized omnichannel promotion. The new marketing paradigm requires large amounts of customer data and internal data, as well as coordination across channels. To fully transform management models, the key is how to effectively acquire and use data so that it supports business growth and value creation.
BeiGene is a global biotechnology company focused on developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and drug access for patients worldwide. In digital asset management, the company sought an efficient, secure, and compliant way to optimize data use and build more personalized user interactions.
"During digital transformation, we have already built multiple platforms, including a next-generation customer engagement platform and an intelligent call center. But these diverse information sources also created the problem of scattered content," said Gu Weihong, associate director of information technology in BeiGene's Global Technology Solutions department. "We needed to build a full-lifecycle content management platform. Through refined approval and permission management, we wanted to manage data in different formats uniformly, deliver high-quality customer digital experiences and secure data use, and meet the strict compliance requirements of the pharmaceutical industry."
Based on this need, ADAL, the All-in-One Digital Assets Library, was created. The solution is designed to help enterprises comprehensively manage digital assets, from content approval management and privacy management to user behavior tracking and analysis, improving customer digital experience, business user capabilities, and content management efficiency.
BeiGene has always been at the forefront of digital management in the industry. By building an integrated digital asset management platform, the ADAL project helps make our academic promotion more precise, effective, and compliant.
- Ji Yang, Chief Compliance Officer, BeiGene
Provide a Tagging System and Industry-Focused Algorithms
Build an Integrated Digital Asset Management Solution
The successful application of ADAL depended on support from professional solution providers. When selecting service providers, BeiGene evaluated professional capabilities, customer experience, solution functions, and other factors, then chose a combined solution from AWS partners including MeDomino, deployed on AWS.
MeDomino, as an AWS partner, provides HCP profiling, internal and external data integration, public-channel data-based estimation of HCP influence and treatment mindsets, and precise content positioning to relevant HCPs by integrating physician data and intelligent content suggestions. This links HCP tags with intelligent content recommendations and empowers enterprises to deliver academic information and marketing activities efficiently and precisely. MeDomino's HCP360 product can rapidly help clients find the right physicians, turn massive data into physician tags, facilitate precise audience package selection and outreach, help pharma and medtech companies manage internal and external content, automatically tag content, combine it with physician tags for personalized engagement and distribution, and use returned data to enrich physician profiles.
MeDomino provided BeiGene with a customized tagging system to classify, group, and control content in a way tailored to the pharmaceutical industry. Embedded algorithms in the solution support one-click upload and processing of multimodal files, automatically combine professional medical terminology to extract text tags, organize content by multidimensional tags, and adjust or modify the system according to users' business habits. With automated tag processing algorithms, MeDomino helped BeiGene process large volumes of data quickly, accurately, and continuously. Compared with manual processing, MeDomino's AWS-based solution not only improved data processing efficiency and consistency, but also continuously reviewed and maintained tag usage, ensuring the completeness and effectiveness of both the tagging system and file tags.
Supported by Amazon EC2 accelerated computing instances, the ADAL solution has high-performance data processing and analysis capabilities. This instance type is designed for deep learning and high-performance computing scenarios, allowing MeDomino to complete massive multimodal data processing and analysis in less time and present results to users. Gu Weihong, associate director of information technology in BeiGene's Global Technology Solutions department, said, "Through our collaboration with MeDomino, we successfully delivered the ADAL project, improved the speed of content creation, approval, and distribution, and accelerated internal material generation. We also achieved automated publishing processes and flexible user permission management, greatly reducing the risk of content leakage."
Building on the successful ADAL integrated digital asset management project, BeiGene plans to deepen cooperation with AWS and its partner MeDomino in data tagging and intelligence, using advanced AI capabilities on the cloud to further improve data use efficiency and discover more business value. With AI technology, the platform can support more precise content recommendation and knowledge base question retrieval, as well as document assistant functions. These technologies make document search more direct and efficient, answer user questions instantly, and further improve ADAL's intelligence and user experience.
Win Together and Upgrade Together
Build Solutions for Healthcare and Life Sciences
MeDomino is committed to supporting biotechnology and pharmaceutical users in digital transformation and upgrades. By using data and specialized solutions, MeDomino helps enterprises achieve multichannel digital pharmaceutical marketing, allowing medical affairs, marketing, data analytics, and other business teams to gain needed insights from professional solutions and realize business value. This improves enterprise operational efficiency, brings more value to industry clients, and promotes overall industry development. MeDomino's professional capabilities and solutions will become an important force driving digital transformation in biotechnology and pharma.
Looking ahead, MeDomino, as an AWS partner, will work with AWS to build more digital intelligence solutions for healthcare marketing. These solutions will cover customer profiling, customer tags, content management, intelligent recommendations, and other areas, combining AWS's innovative cloud services to provide healthcare clients with secure, compliant, and efficient services, jointly promoting industry development. In addition, MeDomino has worked with AWS to list products such as HCP360 and MeDomino Content Hub on AWS Marketplace, enabling more industry users to use professional solutions through convenient subscription models, expand market scale, and achieve sustainable business growth.
About BeiGene and MeDomino
BeiGene is a global biotechnology company focused on developing innovative oncology medicines for patients worldwide. Through strong in-house R&D capabilities and external strategic partnerships, BeiGene continues to accelerate development of a diverse and innovative pipeline and portfolio, aiming to improve drug access and affordability for more patients worldwide. With more than 10,000 employees across five continents, BeiGene has major offices in Beijing, China; Cambridge, Massachusetts; and Basel, Switzerland. For more information, visit www.beigene.com.cn or follow BeiGene's official WeChat account.
Founded in 2016, MeDomino is a comprehensive and long-term digital intelligence partner for the life sciences industry and a pioneer in industry digital intelligence. It is committed to using data, algorithms, and digital tools to drive business growth and efficiency improvement. MeDomino continues to grow rapidly, with offices and teams in Beijing and Shanghai. It has been recognized as a national high-tech enterprise, Zhongguancun high-tech enterprise, and Beijing innovative small and medium-sized enterprise, and has obtained ISO9001, ISO27001, and other certifications. Based on industry compliance and information security requirements, MeDomino was also the fourth company across related cross-industry enterprises to obtain group-standard consistency certification. Years of technical accumulation have also resulted in substantial independent intellectual property, including algorithm invention patents and software copyrights.
